IRCT20120415009472N20招募中2 期
Effects of Rosemary (Rosmarinus officinalis) Leaves Powder And Weight Reducing Diet on Lipid Profile, Glycemic Status And Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease
Vice-chancellor for research Iran University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 65 years（—）
- 性别
- All
入选标准
- •Desire to participate in studying and signing consent
- •Diagnosis of non-alcoholic fatty liver according to criteria of the American Gastroenterology Association (33): Evidence of hepatic steatosis in liver ultrasound (grade 1 to 3 fatty liver), ALT and AST increased than normal (AST> 38 and ALT> 40 for men and more than 31 and 33 for women), the absence of conditions or diseases secondary to hepatic steatosis, including: alcohol consumption, hereditary disorders affecting liver status (hemochromatosis and Wilson's disease), Known autoimmune disease, history of hepatotoxic drugs (methotrexate, aminodarone, tamoxifen, nifedipine, corticosteroids, valproate, and medications) The virus) and non-use of anticoagulant drugs such as aspirin.
- •Not getting other diseases and chronic and acute liver disorders (hepatitis B, C, etc.), cirrhosis, celiac disease, diabetes, thyroid disorders, cardiovascular, kidney, pulmonary and inflammatory diseases (rheumatism)
- •BMI in the range of 40-25 Kg / m2
- •The age range is 20 to 65 years
- •No use of any nutritional supplements in the past two months
- •No use of weight-effective drugs over the past two months
- •Not having a weight loss diet (a decrease of more than 10% of the weight) over the past three months
- •Do not use drugs and cigarettes
- •No pregnancy or lactation
排除标准
- •Secondary conditions that lead to hepatic steatosis, including: alcohol consumption, hereditary disorders affecting liver status (hemochromatosis and Wilson's disease), and known autoimmune diseaseOther chronic and acute liver diseases and disorders such as hepatitis, cirrhosis, celiac disease, diabetes, thyroid disorders, cardiovascular, renal, pulmonary and inflammatory diseases (rheumatism)History of taking hepatotoxic drugs (methotrexate, amiodarone, tamoxifen, nifedipine, corticosteroids, valproate and antiviral drugs) as well as anticoagulants such as aspirin
- •Use of any nutritional supplement in the past two months
- •Use of weight-loss drugs over the past two months
- •Having a severe weight loss diet (more than 10% weight loss) over the past three months
- •Pregnancy or lactation
研究者
相似试验
招募中
2 期
Effects of Rosemary (Rosmarinus officinalis) Leaves Powder And Weight Reducing Diet on Hs-CRP, MDA, TAC, Blood Pressure, Anthropometric measurement, Quality of life, Sleep and Appetite in Patients with Non-Alcoholic Fatty Liver Diseaseonalcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20120415009472N19Vice-chancellor for research Iran University of Medical Sciences120
尚未招募
2 期
Effect of Rosemary (Rosmarinus officinalis) leaves powder in type 2 diabetes patientsIRCT20120415009472N23Vice-chancellor for research Iran University of Medical Sciences90
进行中（未招募）
不适用
The effect of rosemary use in decreasing symptoms of Common Mental Disorders in prison workers and persons deprived of their libertyeurotic DisordersF03.080RBR-102nsx22niversidade Regional do Noroeste do Estado do Rio Grande do Sul
已完成
3 期
The Effect of Rosemary Essential Oil on Severity of Inflammation and Pain Due to Needle Entry to Intravenous Arterial Fistula in Hemodialysis PatientsIRCT20191028045263N1Ahvaz University of Medical Sciences60
招募中
不适用
Evaluating the effects of Rosmarinus officinalis L. on memory function, mental health, sleep quality and oxidative stress in university studentsCondition 1: Memory. Condition 2: Depression. Condition 3: Anxiety. Condition 4: Sleep disorder.Mild cognitive disorderDepressive episode, unspecifiedAnxiety disorder, unspecifiedSleep disordersIRCT201703136026N6Kerman Univesity of Medical Sciences50